Objective: Pandemic flu has changed the epidemiology of pneumonia, thus challenging the prediction of etiology and outcome. We analyze the risk factors to predict influenza A/H1N1 infection in patients with pneumonia, and the impact of this etiology on mortality during a pandemic period. Differences between pneumonia with or without A/H1N1 coinfection are described. Methods: Retrospective observational study in 364 consecutive patients hospitalized with pneumonia during the A/H1N1 pandemic flu, AprileDecember 2009. Results: 294 patients (80.5%) had A/H1N1(À) pneumonia, 47 (13.2%) A/H1N1(þ) pneumonia, and 23 (6.3%) coinfection. Mortality during hospitalization was 24/294 (8.2%), 8/47 (16.7%), 2/23 (8.7%) respectively. A regression logistic analysis (Area under curve, AUC 0.81) to predict A/H1N1(þ) pneumonia identified four independent variables: age < 60 years (Odds ratio, OR 5.9), multilobar infiltrates (OR 7.7), C-reactive protein (CRP) < 10 mg/dL (OR 2.8), and leukopenia < 5000/mm 3 (OR 3.4). Risk factors for in-hospital mortality in the whole group were A/H1N1 (þ) etiology and LDH > 600 IU/L (OR 4.1) when adjusting for PSI, and hypoxemia (OR 4.2) when adjusting for CURB 65 (AUC 0.81). Heart disease (OR 27.4) and LDH > 600 IU/L (OR 10.5) were risk factors for in-hospital mortality in A/H1N1(þ) patients (AUC 0.81) Conclusion: Leukopenia, multilobar infiltrates, CRP<10 mg/dl and age < 60 years were independently associated with A/H1N1(þ) etiology. Pandemic A/H1N1(þ) increased mortality pneumonia. Heart disease and LDH > 600 were independently associated with mortality in A/H1N1(þ) pneumonia. ª (S. Reyes). a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / r m e d Respiratory Medicine (2011) 105, 1404e1411 0954-6111/$ -see front matter ª
Introduction
Pneumonia is a severe infection with high morbidity and mortality worldwide. The emergence of a novel influenza virus A/H1N1, with a high degree of human transmission, has changed the epidemiology, clinical pattern and prognosis of pneumonia. During the A/H1N1 pandemic influenza an increased incidence of pneumonia has been reported and, thus, both primary viral and mixed etiology (Influenza plus Streptococcus pneumoniae and Staphylococcus aureus) pneumonia have been described. 1e5 Clinical course, severity of disease and outcome differ among these three clinical pneumonia scenarios.
The clinical diagnosis of pneumonia, irrespective of bacteria or virus etiology, is based on signs and symptoms along with analytical results and the finding of a new infiltrate in radiograph. Traditionally, signs and symptoms have been considered highly unspecific to predict causal microorganisms in pneumonia, so they are not usually taken in account for selecting empirical treatment in current guidelines. 6e8 Nevertheless, the pandemic influenza has showed a different epidemiological pattern, 3,9e13 and the incidence and impact of coinfection with bacteria is not completely known. An adequate treatment selection, both in bacterial 14e16 and in A/ H1N1(þ) pneumonia, 17, 18 is key because it has been proved to be an important protective factor against mortality. In fact, the importance of initiating early empiric treatment in order to improve prognosis is an important task in hospitalized patients with severe pneumonia. 19 The biological marker C-reactive protein (CRP) has been evaluated as a diagnostic or prognostic tool in lower respiratory tract infections and pneumonia. 20e24 Our hypothesis is that, CRP levels added to other clinical and/or analytical parameters might be helpful to predict the etiology of pneumonia during pandemic flu. We consider that estimating the pretest probability of viral etiology is useful for clinicians in order to prescribe a combination therapy (antibiotic and antiviral), or to select the main candidates for performing viral microbiological studies. This information might be valuable to maintain high suspicion in next successive waves. Recently, the association of CRP>10 mg/dl with severe outcomes in A/H1N1 pandemic influenza, independently of pneumonia, has been demonstrated. 25 However, the behavior of CRP as a prognostic biomarker in pneumonia is not well known during an epidemic flu wave.
The aim of our study was to identify risk factors to predict influenza A/H1N1 etiology in pneumonia. As a secondary aim, we evaluated the impact of the A/H1N1 etiology on pneumonia mortality. Furthermore, we aimed to describe differences between the presence and absence of bacterial coinfection in those patients with A/H1N1 pneumonia.
Material and methods

Study subjects and design
This study was conducted in a Spanish tertiary hospital. Data were collected retrospectively on all patients with pneumonia admitted to the Pneumology department or to the Intensive Care Unit (ICU), with or without influenza A/H1N1 infection, according to case definitions developed by the World Health Organization. 26 The study period lasted from April 26th to December 30th 2009. Pneumonia was defined as symptoms and/or signs of lower respiratory tract infection (e.g. temperature>38 C, productive cough, chest pain, shortness of breath, crackles on auscultation) and the presence of a new infiltrate on chest radiograph. Immunosuppressed patients were included in the study during the pandemic period. We excluded patients hospitalized in the previous 15 days. A/H1N1(þ) pneumonia was defined as pneumonia plus a positive real-time reverse transcription-polymerase chain reaction (RT-PCR), bacterial coinfection was defined as A/H1N1(þ) etiology plus a proven bacterial diagnosis.
The study was approved by the Ethics Committee of the University Hospital La Fe, Valencia (Spain). The data were coded to keep anonymity of the patients; informed consent was waived because of the non-interventional study design.
Methods
Data collection
The protocol for data collection included: age, sex, smoking and alcohol consumption, vaccination status in 2008e2009, pregnancy, comorbid conditions (chronic obstructive pulmonary disease (COPD), asthma, heart, liver, neurological, renal, or neoplastic diseases, diabetes mellitus, immunosuppression). Obesity was defined as a body mass index (kg/m 2 ) >30. We recorded clinical signs, symptoms, analytical data and radiological findings in the first 24 h. Collected symptoms and signs were headache, cough, expectoration, chest pain, dyspnea, confusion, diarrhea, fever>38 C, heart rate, respiratory rate and blood pressure. The analytical data included leukocyte, neutrophil and lymphocyte counts, sodium, potassium, serum creatinine, glucose, blood urea nitrogen (BUN), creatin kinase (CK), lactate dehydrogenase (LDH), CRP, and arterial blood gas analysis. Radiological findings were also documented: multilobar (!2) or bilateral infiltrates, and pleural effusion. The Pneumonia Severity Index (PSI) 27 and CURB 65 28 were calculated in all patients.
At diagnosis, antibiotic and antiviral therapy with oseltamivir was prescribed in all patients. Antibiotics were prescribed according to the Spanish guidelines, Sociedad Española de Neumología y Cirugía Torácica (SEPAR). 6, 7 Oseltamivir was subsequently discontinued in patients with RT-PCR negative results.
Microbiologic studies
Several samples were obtained for microbiological studies: 1) Nasopharyngeal swab specimens to detect influenza virus, n Z 364 (100%); 2) blood cultures, n Z 289 (79.2%); 3) serum for paired serology (at admission and after 4 weeks) for Chlamydophila pneumoniae, Mycoplasma pneumoniae, Coxiella burnetii and Legionella pneumophila, n Z 91 (24.9%); 4) urine to detect antigens of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae using an immunochromatographic test, n Z 350 (95.9%); and 5) respiratory samples, by valid sputum, n Z 164 (44.9%), (representative sputum originating from the lower respiratory tract was defined as that containing 25 granulocytes and 10 epithelial cells per low power field (total magnification: x100), by flexible fiberoptic bronchoscopy, n Z 27 (7.4%), or pleural liquid, n Z 14 (3.8%), were obtained according to the clinical judgment of the physician in charge.
Microbiological diagnostic criteria
A/H1N1 influenza virus infection was diagnosed by RT-PCR, in accordance with published guidelines from the U.S. Centers for Disease Control and Prevention (CDC) 29 . The bacterial etiology was established by: 1) positive urinary antigens of Streptococcus pneumoniae or Legionella pneumophila; 2) blood cultures or pleural fluid yielding a bacterial pathogen; 3) bacterial growth >10 5 cfu/ml in bronchoaspirate, >10 4 cfu/ml in bronchoalveolar lavage fluid, or if a valid sputum sample yielded one or more predominant bacterial strains; 4) serology criteria, i.e., a fourfold increase in IgG titers for Chlamydophila pneumoniae (>1:512), Chlamydophila psittaci (>1:64), Legionella pneumophila (>1:128), Coxiella burnetii (>1:80) or a single increased IgM titer for Chlamydophila pneumoniae (>1:32), Coxiella burnetii (>1:80), and Mycoplasma pneumoniae (any titer).
Coinfection was defined as present bacterial criteria along with positive RT-PCR results.
Analysis
Data analysis was performed using SPSS 15.0 software. Categorical variables results are expressed as counts (percentage) and continuous variables as medians with interquartile range (IQR). We classified the group into three subsets: A/H1N1(À) pneumonia, A/H1N1(þ) pneumonia, and coinfection. The in-hospital mortality analyses were performed in the whole group and in the subset of A/H1N1(þ) pneumonia.
Univariate analysis was performed using chi square test for categorical variables and ManneWhitney U and Krustall-Wallis ANOVA tests for continuous variables. Four multivariate stepwise logistic regression analyses were performed: the first model to predict A/H1N1 (þ) etiology, two models to predict mortality in the whole cohort -one adjusting for PSI and another adjusting for CURB 65-, and the last model to predict in-mortality of A/H1N1 (þ) pneumonia. Independent variables included in the four models were those found significant in univariate analyses and those considered clinically relevant such as pregnancy, obesity, comorbidities and hypoxemia.
In the first model, influenza A/H1N1(þ) etiology was the dependent variable and as independent variables we included age, cough, diarrhea, respiratory rate, BUN, multilobar infiltrates, pleural effusion, leukopenia, CRP, LDH and CK. In the second (adjusting for PSI) and third model (adjusting for CURB 65), in-mortality in the whole group was the dependent variable and the independent variables were multilobar infiltrates, leukopenia, CRP, LDH, CK, and A/H1N1(þ) etiology. In the fourth model, inmortality of A/H1N1(þ) pneumonia was the dependent variable and the independent variables were multilobar infiltrates, leukopenia, CRP, LDH, CK.
The independent variables were dichotomized as follows: age, using the median (<60: yes/no), PSI was categorized as high (Fine risk classes IVeV) or low risk (classes IeIII), CURB 65 was categorized as high risk !3 or low 2, leukopenia (<5000/mm 3 : yes/no), hypoxemia (PO 2 <60 mmHg:yes/no), CRP (<10 mg/dl: yes/no), CK (!90 IU/L: yes/no), LDH (!600 IU/L: yes/no).
To calculate the predictive value of the model, we calculated the area under the ROC curve of the multivariate logistic regression analysis to predict infection by influenza A/H1N1 and mortality. Hosmer-Lemeshow and goodness of fit tests were performed for each model. 30 
Results
Study population
The study comprised 364 patients: 294 (80.5%) A/H1N1(À) pneumonia patients, 47 (13.2%) A/H1N1(þ) pneumonia, and 23 (6.3%) A/H1N1(þ) and bacterial coinfection. Etiology in patients with A/H1N1(À) pneumonia was as follows: 
Univariate analysis
Demographics, comorbidity, initial severity The main demographic characteristics, comorbidity and initial severity measured by PSI are shown in Table 1 . We found more pregnant women and patients <60 years, and less comorbid conditions (diabetes, liver, heart or neoplastic diseases and neurological disorders) in the A/H1N1(þ) pneumonia group. In patients with A/H1N1(À) pneumonia a higher age was found (p:0.0001), as well as higher scores of PSI (p:0.0001).
Twenty-three patients with A/H1N1(þ) pneumonia had coinfection, and comparing to those with A/H1N1 infection alone there were more cases with COPD (p:0.006) and immunosupression (p:0.058).
Clinical, analytical and radiological findings Headache (p:0.03) and cough (p:0.002) were more frequent in A/H1N1(þ) pneumonia. No differences were found concerning other symptoms and physical signs. Median time from the onset of illness to hospital admission was lower in patients with A/H1N1(À) than in those with A/H1N1(þ) pneumonia (3 vs 6 days, p:0.0001).
Analytical parameters and radiological findings in the three subsets are shown in Table 2 . In patients with A/H1N1(þ) pneumonia, irrespective of coinfection, we found significantly higher levels of LDH (p:0.004) and CK (p:0.007) compared to those with A/H1N1(À) pneumonia. However, CRP was significantly lower in A/H1N1(þ) pneumonia without bacterial coinfection compared to the other two subsets. Using the CRP selected cut-off value of 10 mg/dl we found that 20/23 (87.0%) of patients with coinfection had higher levels compared to 20/47 (42.6%) of those with A/H1N1(þ) pneumonia alone, (p:0.0001). Multilobar and/or bilateral infiltrates were more frequent in A/H1N1(þ) pneumonia (p:0.0001), while pleural effusion was more common, although not significantly, in A/H1N1(À) pneumonia (p:0.1).
Mortality
Thirty four patients died during hospitalization: 24 (8.2%) of those with A/H1N1(À) pneumonia, 8 (16.7%) of those with A/H1N1(þ) pneumonia and 2 (8.7%) of those with coinfection.
In Table 3 we show data of age, comorbid conditions, analytical parameters and radiological findings of patients who died. In A/H1N1(À) pneumonia, in-hospital mortality was higher in elderly patients, in those with neurological disorders and higher scores of PSI. In the subset of A/H1N1(þ) pneumonia patients, we found lower age, higher LDH and lower scores of PSI.
In Table 4 , medians of CRP and LDH in the three subsets are shown. Although CRP and LDH were higher in those who died in A/H1N1(þ), the difference did not reach statistical significance, probably due to a beta error. Significantly higher levels of LDH were found in those who died in A/H1N1(À) pneumonia.
Multivariate analyses
Four logistic regression analyses were performed: one to predict influenza A/H1N1(þ) pneumonia, two to predict in-hospital mortality in the whole group, and one to predict in-mortality in A/H1N1 (þ) pneumonia. The first mathematical model selected the following variables to predict influenza A/H1N1 infection (Table 5) : age, multilobar infiltrates, CRP and leukopenia. The AUC of the model was 0.81 (0.75e0.88).
The mathematical models to predict in-hospital mortality are also depicted in Table 5 . In the whole group, the independent variables that were associated with higher mortality were: A/H1N1 etiology, high severity, LDH>600 IU/L (adjusting for PSI) and hypoxemia (adjusting for CURB 65) (AUC 0.85; 0.79e0.90). The risk factors of mortality in A/H1N1(þ) pneumonia were the presence of heart disease and LDH>600 IU/L (AUC 0.81; 0.65e0.97).
The Chi-squared goodness-of-fit analysis demonstrated the adequacy of the models (p > 0.05).
Discussion
The most important findings of our study can be summarized as follows. 1) associated factors of A/H1N1(þ) etiology in pneumonia were age<60, multilobar infiltrates, CRP<10 mg/dL, and leukopenia < 5000/mm 3 ; 2) Coinfection appeared in 33% of A/H1N1 pneumonia, mainly in COPD and immunosupressed patients; 3) pneumonia mortality during pandemic A/H1N1 was independently associated with A/H1N1(þ) etiology and LDH>600 IU/L (when adjusting for PSI) or hypoxemia (when adjusting for CURB 65); and 4) mortality risk factors for A/H1N1(þ) pneumonia were heart disease and LDH>600 UI/L.
The appearance of the new influenza pandemic A/H1N1 has challenged even more our capacity to predict bacterial or viral etiology in pneumonia. Clinicians must maintain a high suspicion level of viral etiology, as rapid diagnostic tests and/or PCR are not available in all hospitals. Therefore, recommended empiric treatment in hospitalized pneumonia during pandemic A/H1N1 included an antibiotic along with antivirals, a combination due to the difficulty of presuming viral or bacterial etiology. 31 The potential role of biomarkers in this new scenario merits attention in order to improve diagnosis and prognosis.
In our study, we found demographic and comorbid conditions in A/H1N1(þ) pneumonia similar to prior publications. 9e11, 13, 32, 33 Regarding coinfection, patients were older than those with A/H1N1(þ) alone and had more often comorbid conditions such as COPD or immunosupression, as reported by Estenssoro et al. 4 . Martin-Loeches et al, 3 didn't find differences in comorbidities, although they reported more frequent coinfection in elderly patients and in those with higher initial severity. Analytical parameters showed higher levels of LDH and CK and lower counts of leukocytes in A/H1N1(þ) than in bacterial pneumonia. Interestingly, the clinical pattern of coinfection shares characteristics of both etiologies. Leukocyte and neutrophyl counts showed higher levels in bacterial etiology, intermediate in coinfection and lower in A/H1N1(þ) pneumonia. CRP also behaved differently in viral and bacterial etiology: lower in A/H1N1(þ) than in bacterial pneumonia, while it was higher in coinfection. Radiological findings showed pleural effusion more often in bacterial etiology (14 vs. 6%) while multilobar infiltrates were predominant in A/H1N1(þ) pneumonia, irrespective of coinfection.
The multivariate statistical analysis to predict A/H1N1(þ) pneumonia selected CRP below 10 mg/dL (OR 2.8) as an independent variable, along with age<60 (OR 5.9) multilobar infiltrates (OR 7.7), and leukopenia (OR 3.4). The AUC of the model to predict viral etiology was 0.81, quite a high diagnostic accuracy. If age is not included in the model, assuming that epidemiology of A/H1N1 in successive waves could change, the remaining three risk factors retained a high diagnostic value (data not shown), with an AUC of 0.80 (0.74e0.86). Moreover, CRP >10 mg/dL in A/H1N1(þ) pneumonia should alert the clinician about coinfection with bacteria. Ingram et al, 34 in critically ill A/H1N1(þ) patients, reported that bacterial infection or coinfection with A/H1N1, was unlikely when CRP is low. CRP is available in most hospitals and has the potential to aid for suspecting viral pneumonia, and to initiate a combination of antiviral þ antibiotics in order to avoid a delayed treatment. In A/H1N1(þ) pneumonia, the most common prognostic scales, PSI and CURB 65, proved useless to predict mortality, as previously reported. 35, 36 Concerning mortality, CRP was higher although without reaching statistical significance. That finding is opposite to its confirmed usefulness in community-acquired pneumonia to predict complications and mortality. 24, 37, 38 That is, during pandemic flu, its interpretation as a biomarker for mortality should be more cautious. However, in influenza A/H1N1 patients (71% without pneumonia and including a pediatric population) the threshold of CRP>10 mg/dl has been associated with severe outcomes and mortality. 25 On the other hand, we found that LDH behaved as a better biomarker than CRP to predict mortality, 9, 32, 39 keeping its independent association in the multivariate analysis. Although several publications have reported higher levels of CK in those patients who died, 9, 40 we did not find this association, such as Kumar et al. 12 Mortality of pneumonia during pandemic flu showed interesting findings. We confirmed that, after adjusting for PSI or CURB 65, A/H1N1 etiology was an independent factor for mortality. Our findings confirmed a higher mortality in influenza A/H1N1 pneumonia compared to A/H1N1(À) pneumonia. 11, 13, 32 Multilobar infiltrates and hypoxemia were also independent risk factors for mortality. 41 The independent predictors of mortality in A/H1N1(þ) pneumonia were the presence of heart disease (OR 27.4) and LDH>600 IU/L (OR 10.5). Cardiovascular involvement in acute influenza infection can occur through a myocardium direct effect or through exacerbation of previous disease. 42, 43 Interestingly, mortality in coinfection was lower than in A/H1N1 pneumonia alone, although the low number of cases precludes us from reaching firm conclusions. In a study of necropsies it was reported that a bacteria was found in 30% of A/H1N1 infection, 44 and it was more frequent in pediatric patients. 40, 45 One limitation of our study is its retrospective design, although we used a standardized data collection form used in pneumonia studies in our hospital. Furthermore, we included all consecutive patients during the pandemic period and all of them were investigated for A/H1N1. Other limitations are that the rate of coinfection may have been underestimated and that the subsets of A/H1N1(þ) pneumonia and coinfection are small.
In conclusion, some findings such as leukopenia, multilobar infiltrates along with CRP<10 with have a good diagnostic value to predict A/H1N1 pneumonia. A high level of CRP should alert about coinfection with bacteria in A/H1N1 pneumonia. During pandemic flu, CRP could lose its predictive value for mortality whereas a raised LDH behaved as a better biomarker of poor outcome in pneumonia.
